The US pharmacy market
is projected to grow at a CAGR of approximately 5-6% from 2024 to 2029, driven
by increasing prescription drug usage, an aging population, and technological
advancements. Despite robust growth, the market faces challenges such as
regulatory complexities and rising operational costs, which require continuous
innovation and adaptation.
The US pharmacy market comprises the retail, online, and
specialty distribution of prescription drugs, over-the-counter (OTC)
medications, and related healthcare products. It serves as a key touchpoint for
patients to access medications and healthcare advice, enhancing public health
and medication adherence. The market also includes clinical services like
immunizations, medication management, and telepharmacy. With the integration of
digital technologies, the pharmacy landscape is rapidly evolving to meet the
demands of a modern, patient-centric healthcare ecosystem.
Download a free sample report now 👉
https://meditechinsights.com/us-pharmacy-market/request-sample/
Growing Role of Pharmacies in Chronic Disease Management
The increasing prevalence of chronic diseases such as
diabetes, hypertension, and cardiovascular conditions is boosting the demand
for pharmacy services in the US. Consistent access to medications and care
services has become essential to managing these conditions effectively.
Pharmacies contribute to this by supporting medication adherence through refill
reminders, personalized counselling, and compliance programs. They also act as
accessible points for preventive care services, including flu vaccinations and
health screenings. With healthcare systems placing greater emphasis on
long-term disease management and preventive care, pharmacies are evolving into
essential hubs for patient-focused healthcare delivery, enhancing their role in
the broader healthcare framework.
Transformative Impact of Online and Telepharmacy Services
The growth of online and telepharmacy services is
revolutionizing the US pharmacy market. With the rise of digital health technologies,
pharmacies now offer virtual consultations, e-prescription services, and
doorstep delivery of medications. These advancements cater to consumers seeking
convenience and accessibility, especially in rural areas and for individuals
with limited mobility. The COVID-19 pandemic further accelerated this shift,
normalizing the use of telehealth platforms for pharmaceutical
services. As a result, pharmacies are expanding their digital presence and
investing in AI-driven tools to provide personalized healthcare solutions. The
integration of telepharmacy with wearable devices and health apps also fosters
proactive health management, making pharmacy services more adaptive and
inclusive. Furthermore, digital platforms empower pharmacists to monitor
patient adherence remotely, reducing medication errors and improving outcomes.
As healthcare evolves, telepharmacy is expected to play a crucial role in
enhancing collaborative care between patients, pharmacists, and healthcare
providers.
Competitive Landscape Analysis: US Pharmacy Market
Some of the key players operating in the US pharmacy market
include CVS Health; Walgreens Boots Alliance, Inc.; Walmart
Stores, Inc.; Cigna Healthcare; Rite Aid Corporation; The Kroger
Company; Albertsons Companies, Inc; UnitedHealth Group (OptumRx); Cardinal
Health, Inc and Humana Pharmacy Solution.
Download a sample report for in-depth competitive
insights
https://meditechinsights.com/us-pharmacy-market/request-sample/
US Pharmacy Market Segmentation
This report by Medi-Tech Insights provides size of the US
pharmacy from 2022 to 2029. The report further segments the market on the basis
of type, product type and ownership.
- Market
Size & Forecast (2022-2029), By Pharmacy Type, USD Million
- Hospital
Pharmacy
- Retail
Pharmacy
- ePharmacy
- Others
- Market
Size & Forecast (2022-2029), By Product Type, USD Million
- Prescription
- OTC
- Market
Size & Forecast (2022-2029), By Ownership, USD Million
- Independent
- Chain
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research
& insights firm. Our clients include Fortune 500 companies, blue-chip
investors & hyper-growth start-ups. We have completed 100+ projects in
Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key
demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Comments
Post a Comment